share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  08/30 16:28

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Director and Officer, JEFFREY LEIDEN, is set to sell 3,784 shares of the company's common stock on 08/30/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $1,866,836.40, were acquired on 02/07/2024 through a Restricted Stock Unit/Performance Stock Unit (RSU/PSU) transaction with the issuer. This planned sale follows a period where no other securities transactions were reported by LEIDEN in the past three months. The notice of the intended sale was filed on the same date as the planned sale, with the instruction for the sale having been given earlier on 05/10/2024.
Vertex Pharmaceuticals Director and Officer, JEFFREY LEIDEN, is set to sell 3,784 shares of the company's common stock on 08/30/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $1,866,836.40, were acquired on 02/07/2024 through a Restricted Stock Unit/Performance Stock Unit (RSU/PSU) transaction with the issuer. This planned sale follows a period where no other securities transactions were reported by LEIDEN in the past three months. The notice of the intended sale was filed on the same date as the planned sale, with the instruction for the sale having been given earlier on 05/10/2024.
福泰製藥的董事兼高級職員 JEFFREY LEIDEN 打算於 2024 年 08 月 30 日出售公司的 3,784 股普通股,根據最近的申報公告。這些股票的市場價值爲 $1,866,836.40,是在 2024 年 02 月 07 日通過受限制股票單位/績效股票單位(RSU/PSU)交易獲得的。這次計劃的賣出是在 LEIDEN 在過去三個月裏沒有報告其他證券交易的時期之後進行的。擬議銷售的通知以及賣出的指令都在 2024 年 05 月 10 日之前提交。
福泰製藥的董事兼高級職員 JEFFREY LEIDEN 打算於 2024 年 08 月 30 日出售公司的 3,784 股普通股,根據最近的申報公告。這些股票的市場價值爲 $1,866,836.40,是在 2024 年 02 月 07 日通過受限制股票單位/績效股票單位(RSU/PSU)交易獲得的。這次計劃的賣出是在 LEIDEN 在過去三個月裏沒有報告其他證券交易的時期之後進行的。擬議銷售的通知以及賣出的指令都在 2024 年 05 月 10 日之前提交。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息